ET-600 (DESMODA) PDUFA Date (Eton Pharmaceuticals)

Name: FDA PDUFA Decision: ET-600 (DESMODA)
Start: 2026-02-25

FDA PDUFA decision date for ET-600 (DESMODA) is February 25, 2026. Developed by Eton Pharmaceuticals. Indication: Central diabetes insipidus. Current status: Approved.

Indication

Central diabetes insipidus

Regulatory details

Company: Eton Pharmaceuticals
Therapeutic area: Rare Disease / Endocrine
Application type: NDA
Review type: Standard
PDUFA date: 2026-02-25
Outcome: Approved

ET-600 (DESMODA) PDUFA Date — Eton Pharmaceuticals